179 related articles for article (PubMed ID: 16567395)
21. Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.
Enjoji M; Nakamuta M; Arimura E; Morizono S; Kuniyoshi M; Fukushima M; Kotoh K; Nawata H
Int J Biol Markers; 2004; 19(4):322-7. PubMed ID: 15646840
[TBL] [Abstract][Full Text] [Related]
22. Polyamines as markers of response and disease activity in cancer chemotherapy.
Durie BG; Salmon SE; Russell DH
Cancer Res; 1977 Jan; 37(1):214-21. PubMed ID: 830407
[TBL] [Abstract][Full Text] [Related]
23. [Estimation of urinary diacetylspermine in Yusho patients].
Shibata S; Tokunaga S; Furue M
Fukuoka Igaku Zasshi; 2007 May; 98(5):136-40. PubMed ID: 17642287
[TBL] [Abstract][Full Text] [Related]
24. Circadian rhythmicity of polyamine urinary excretion.
Hrushesky WJ; Merdink J; Abdel-Monem MM
Cancer Res; 1983 Aug; 43(8):3944-7. PubMed ID: 6861156
[TBL] [Abstract][Full Text] [Related]
25. Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.
Takahashi Y; Horio H; Sakaguchi K; Hiramatsu K; Kawakita M
BMC Cancer; 2015 Feb; 15():65. PubMed ID: 25884987
[TBL] [Abstract][Full Text] [Related]
26. [Detection of urinary polyamine by a new enzymatic differential assay. (III). Studies on urinary polyamines in patients with malignant genitourinary diseases].
Sakai S; Ito Y; Koide T; Tei K; Hara A; Sawada H
Hinyokika Kiyo; 1986 Mar; 32(3):343-50. PubMed ID: 2425608
[TBL] [Abstract][Full Text] [Related]
27. Interaction of N1,N12-diacetylspermine with polyamine transport systems of polarized porcine renal cell line LLC-PK1.
Miki T; Hiramatsu K; Kawakita M
J Biochem; 2005 Oct; 138(4):479-84. PubMed ID: 16272143
[TBL] [Abstract][Full Text] [Related]
28. [Urine diacetylspermine as a novel tumor marker].
Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
[TBL] [Abstract][Full Text] [Related]
29. [The clinical value of urinary polyamine analysis in urological disease].
Matsuda M; Seguchi T; Sugao H; Nakano E; Okuyama A; Sonoda T
Hinyokika Kiyo; 1988 Oct; 34(10):1703-10. PubMed ID: 3245519
[TBL] [Abstract][Full Text] [Related]
30. [Factors affecting the increase of urinary diacetylspermine levels : a study in patients with liver diseases].
Enjoji M; Kotoh K; Nakamuta M;
Rinsho Byori; 2006 Feb; 54(2):126-31. PubMed ID: 16548232
[TBL] [Abstract][Full Text] [Related]
31. Enhanced urinary excretion of N1-acetylspermidine and the presence of tumors.
Seiler N; Graham A; Bartholeyns J
Cancer Res; 1981 Apr; 41(4):1572-3. PubMed ID: 6897929
[TBL] [Abstract][Full Text] [Related]
32. [Amines and pteridines].
Shimpo K; Chihara T; Hibiya M; Ito S; Nagatsu T
Nihon Rinsho; 1996 Jun; 54(6):1515-20. PubMed ID: 8691603
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of sepsis and trauma on urinary excretion of polyamines.
Pöyhönen MJ; Takala JA; Pitkänen O; Kari A; Alakuijala LA; Eloranta TO
Nutrition; 1993; 9(5):406-10. PubMed ID: 8286878
[TBL] [Abstract][Full Text] [Related]
34. [Polyamines as biochemical markers of malignant tumors and the efficacy of chemotherapy].
Filipović N; Borcić N; Hotić A; Kecman G; Hadziabdić E; Jusufović D
Med Arh; 1983; 37(3):147-50. PubMed ID: 6400851
[No Abstract] [Full Text] [Related]
35. Increase of N1, N12-diacetylspermine in tissues from colorectal cancer and its liver metastasis.
Kuwata G; Hiramatsu K; Samejima K; Iwasaki K; Takahashi K; Koizumi K; Horiguchi S; Moriya SS; Kobayashi M; Kawakita M
J Cancer Res Clin Oncol; 2013 Jun; 139(6):925-32. PubMed ID: 23443255
[TBL] [Abstract][Full Text] [Related]
36. Further evidence for the use of polyamines as biochemical markers for malignant tumors.
Horn Y; Beal SL; Walach N; Lubich WP; Spigel L; Marton LJ
Cancer Res; 1982 Aug; 42(8):3248-51. PubMed ID: 7093963
[TBL] [Abstract][Full Text] [Related]
37. Urinary N
Yokota K; Hinoki A; Hiramatsu K; Amano H; Kawamura M; Kuwatsuka Y; Tainaka T; Shirota C; Sumida W; Makita S; Okamoto M; Takimoto A; Yasui A; Nakagawa Y; Uchida H; Kawakita M
Pediatr Surg Int; 2021 Dec; 37(12):1659-1665. PubMed ID: 34453590
[TBL] [Abstract][Full Text] [Related]
38. Urinary excretion of polyamines by patients with advanced malignancy.
Waalkes TP; Gehrke CW; Tormey DC; Zumwalt RW; Hueser JN; Kuo KC; Lakings DB; Ahmann DL; Moertel CG
Cancer Chemother Rep; 1975; 59(6):1103-16. PubMed ID: 1222394
[TBL] [Abstract][Full Text] [Related]
39. [Urine levels of polyamine in patients with or without cancer].
Tsunoda A
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):816-25. PubMed ID: 3670267
[TBL] [Abstract][Full Text] [Related]
40. Altered Polyamine Profiles in Colorectal Cancer.
Venäläinen MK; Roine AN; Häkkinen MR; Vepsäläinen JJ; Kumpulainen PS; Kiviniemi MS; Lehtimäki T; Oksala NK; Rantanen TK
Anticancer Res; 2018 Jun; 38(6):3601-3607. PubMed ID: 29848716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
